Sun Pharmaceutical Industries Ltd.

The revenue slipped marginally during the December 2021 quarter. A decline of about Rs. 37706.60 millions was observed as compared to Rs. 38696.80 millions during the corresponding quarter last year.Profit saw a slight increase of 10.39%to Rs. 5154.30  millions from Rs. 4669.20 millions.The company reported a good operating profit of 9616.20 millions compared to 8390.90 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202112	202012	% Var	202112	202012	% Var	202103	202003	% Var
Sales	37706.60	38696.80	-2.56	112397.60	103636.90	8.45	128032.10	125319.30	2.16
Other Income	3132.50	501.90	524.13	7966.40	2110.80	277.41	1502.20	15109.20	-90.06
PBIDT	9616.20	8390.90	14.60	27994.50	21051.70	32.98	30862.20	42225.70	-26.91
Interest	854.70	743.20	15.00	2951.70	1593.50	85.23	2569.80	4080.10	-37.02
PBDT	8761.50	7647.70	14.56	25042.80	19458.20	28.70	27396.80	38145.60	-28.18
Depreciation	3552.40	3050.00	16.47	8398.00	7537.60	11.41	5868.10	5615.60	4.50
PBT	5209.10	4597.70	13.30	16644.80	11920.60	39.63	21528.70	32530.00	-33.82
TAX	54.80	-71.50	-176.64	-793.20	-305.10	159.98	131.70	418.60	-68.54
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	5154.30	4669.20	10.39	17438.00	12225.70	42.63	21397.00	32111.40	-33.37
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	25.50	21.68	17.61	24.91	20.31	22.62	24.11	33.69	-28.46